{
    "id": 23,
    "premise": "none",
    "hypothesis": "A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations.",
    "label": "entailment",
    "explanation": "Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nA YAP inhibitor may be effective in inhibiting \u03b2-catenin activity.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations.",
        "history explanation": [
            "0 iteration: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nA YAP inhibitor may be effective in inhibiting \u03b2-catenin activity.",
            "1 iteration: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nA YAP inhibitor may be effective in inhibiting \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells can be effective in treating patients with activating CTNNB1 mutations.",
            "2 iteration: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nA YAP inhibitor may be effective in inhibiting \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nInhibiting \u03b2-catenin activity through a YAP inhibitor can lead to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation.",
            "3 iteration: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nA YAP inhibitor may be effective in inhibiting \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nInhibiting \u03b2-catenin activity through a YAP inhibitor directly leads to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation.",
            "4 iteration: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nA YAP inhibitor may be effective in inhibiting \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nInhibiting \u03b2-catenin activity through a YAP inhibitor directly leads to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, effectively reduces cell proliferation, leading to the treatment of patients with activating CTNNB1 mutations.",
            "5 iteration: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin.\nA YAP inhibitor can inhibit \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which leads to the effective treatment of patients with activating CTNNB1 mutations.",
            "6 iteration: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin.\nA YAP inhibitor can inhibit \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which leads to the effective treatment of patients with activating CTNNB1 mutations.\nThe reduction in cell proliferation caused by a YAP inhibitor's inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations.",
            "7 iteration: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin.\nA YAP inhibitor can inhibit \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which leads to the effective treatment of patients with activating CTNNB1 mutations.\nThe reduction in cell proliferation caused by a YAP inhibitor's inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations.",
            "8 iteration: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin.\nA YAP inhibitor can inhibit \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations.\nThe reduction in cell proliferation caused by a YAP inhibitor's inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations.",
            "9 iteration: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin.\nA YAP inhibitor can inhibit \u03b2-catenin activity.\nInhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNBReducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations.\nThe reduction in cell proliferation caused by a YAP inhibitor's inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations.",
            "10 iteration: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin.\nA YAP inhibitor can inhibit \u03b2-catenin activity, which is necessary for the proliferation of cells caused by activating mutations of CTNNBInhibiting \u03b2-catenin activity reduces the proliferation of cells, which is a key factor in treating patients with activating CTNNB1 mutations.\nA YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations.\nThe reduction in cell proliferation caused by a YAP inhibitor's inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 states that a YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\n(* There is a logical relation Implies(D, Not(C)), Implies(YAP inhibitor is effective, Not(\u03b2-catenin activity)) *)\\n(* From explanation 2, we can infer that the YAP inhibitor is effective. *)\\nthen have \"Effective x\" sledgehammer', 'solving time': 103.34431457519531, 'proof tactics': [], 'code': 'theory clinical_23_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutations :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  \u03b2Catenin :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  \u03b2CateninActivity :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  Treat :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutations x \u2227 Activating x \u2227 CTNNB1 x \u2227 Proliferation y \u2227 Cells y \u2227 \u03b2Catenin z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z\"\\n\\n(* Explanation 2: A YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 \u03b2CateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y \u2227 Effective x\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 Patients y \u2227 Mutations z \u2227 Activating z \u2227 CTNNB1 z\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations. *)\\n  shows \"\u2203x y z e. YAPInhibitor x \u2227 Patients y \u2227 Mutations z \u2227 Activating z \u2227 CTNNB1 z \u2227 Treat e \u2227 Agent e x \u2227 Patient e y \u2227 Effective x\"\\nproof -\\n  (* From the premise, we have known information about YAP inhibitor, patients, and activating mutations of CTNNB1. *)\\n  from asm have \"YAPInhibitor x \u2227 Patients y \u2227 Mutations z \u2227 Activating z \u2227 CTNNB1 z\" <ATP>\\n  (* Explanation 2 states that a YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\n  (* There is a logical relation Implies(D, Not(C)), Implies(YAP inhibitor is effective, Not(\u03b2-catenin activity)) *)\\n  (* From explanation 2, we can infer that the YAP inhibitor is effective. *)\\n  then have \"Effective x\" <ATP>\\n  (* Since the YAP inhibitor is effective, it may treat patients with activating CTNNB1 mutations. *)\\n  (* We can construct an event e where the YAP inhibitor treats the patients. *)\\n  then have \"\u2203e. Treat e \u2227 Agent e x \u2227 Patient e y\" <ATP>\\n  (* Combining all the information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: \u03b2-catenin activity (from Explanatory Sentence 1 and 2)\\nD: YAP inhibitor is effective (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor is effective, Not(\u03b2-catenin activity))\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, E), Implies(YAP inhibitor, treating patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, E is from explanatory sentence 3. *)\\n(* We already have YAPInhibitor x, so we can infer treating patients with activating CTNNB1 mutations. *)\\nthen have \"\u2203x y z e. YAPInhibitor x \u2227 Patient e y \u2227 Mutation z \u2227 Activating z \u2227 CTNNB1 z \u2227 Treat e \u2227 Agent e x \u2227 Patient e y \u2227 MutationCause y z\" sledgehammer', 'solving time': 103.99854850769043, 'proof tactics': [], 'code': 'theory clinical_23_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutation :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"entity \u21d2 entity \u21d2 bool\"\\n  Treat :: \"event \u21d2 bool\"\\n  MutationCause :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutation x \u2227 Activating x \u2227 CTNNB1 x \u2227 Proliferation y \u2227 Cell y \u2227 BetaCatenin z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z\"\\n\\n(* Explanation 2: A YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. BetaCateninActivity x \u2227 Proliferation y \u2227 Cell y \u2227 Mutation z \u2227 Activating z \u2227 CTNNB1 z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause y z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 Mutation z \u2227 Activating z \u2227 CTNNB1 z\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations. *)\\n  shows \"\u2203x y z e. YAPInhibitor x \u2227 Patient e y \u2227 Mutation z \u2227 Activating z \u2227 CTNNB1 z \u2227 Treat e \u2227 Agent e x \u2227 Patient e y \u2227 MutationCause y z\"\\nproof -\\n  (* From the premise, we have the known information about YAP inhibitor and activating mutations of CTNNB1. *)\\n  from asm have \"YAPInhibitor x \u2227 Mutation z \u2227 Activating z \u2227 CTNNB1 z\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, treating patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentence 3. *)\\n  (* We already have YAPInhibitor x, so we can infer treating patients with activating CTNNB1 mutations. *)\\n  then have \"\u2203x y z e. YAPInhibitor x \u2227 Patient e y \u2227 Mutation z \u2227 Activating z \u2227 CTNNB1 z \u2227 Treat e \u2227 Agent e x \u2227 Patient e y \u2227 MutationCause y z\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: \u03b2-catenin activity (from Explanatory Sentence 1 and 2)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: treating patients with activating CTNNB1 mutations (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(\u03b2-catenin activity))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(\u03b2-catenin activity), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), treating patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(treating patients with activating CTNNB1 mutations), \u03b2-catenin activity)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, \u03b2-catenin activity)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, treating patients with activating CTNNB1 mutations)\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(treating patients with activating CTNNB1 mutations), Not(YAP inhibitor))\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(\u03b2-catenin activity), treating patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(\u03b2-catenin activity), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, E is from explanatory sentence 4. *)\\n(* We already have YAPInhibitor x, so we can infer Effective x and Treatment y. *)\\nthen have \"YAPInhibitor x \u2227 Effective x \u2227 Treatment y \u2227 Patient e y \u2227 Mutation y\" sledgehammer', 'solving time': 103.25396800041199, 'proof tactics': [], 'code': 'theory clinical_23_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutation :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  Inhibiting :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Through :: \"entity \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Reducing :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutation x \u2227 CTNNB1 x \u2227 Proliferation y \u2227 Cell y \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z \u2227 BetaCatenin z\"\\n\\n(* Explanation 2: A YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. YAPInhibitor x \u2227 Effective x \u2227 Inhibiting y \u2227 BetaCateninActivity y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. Inhibiting x \u2227 BetaCateninActivity x \u2227 Proliferation y \u2227 Cell y \u2227 Reduce e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Mutation z \u2227 CTNNB1 z \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 y\"\\n\\n(* Explanation 4: Inhibiting \u03b2-catenin activity through a YAP inhibitor can lead to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2. Inhibiting x \u2227 BetaCateninActivity x \u2227 YAPInhibitor y \u2227 Through x y \u2227 Treatment z \u2227 Patient e1 z \u2227 Mutation z \u2227 CTNNB1 z \u2227 Effective z \u2227 Lead e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Proliferation w \u2227 Cell w \u2227 Reducing e2 \u2227 Agent e2 x \u2227 Patient e2 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 Mutation y \u2227 Patient e y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 Effective x \u2227 Treatment y \u2227 Patient e y \u2227 Mutation y\"\\nproof -\\n  (* From the premise, we have known information about the YAP inhibitor and mutation. *)\\n  from asm have \"YAPInhibitor x \u2227 Mutation y \u2227 Patient e y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentence 4. *)\\n  (* We already have YAPInhibitor x, so we can infer Effective x and Treatment y. *)\\n  then have \"YAPInhibitor x \u2227 Effective x \u2227 Treatment y \u2227 Patient e y \u2227 Mutation y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: \u03b2-catenin activity (from Explanatory Sentence 1 and 2)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(\u03b2-catenin activity))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(\u03b2-catenin activity), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), \u03b2-catenin activity)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, \u03b2-catenin activity)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(\u03b2-catenin activity), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(\u03b2-catenin activity), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "3 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, E is from explanatory sentence 4. *)\\n(* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)\\nthen have \"Effective x \u2227 Treating y \u2227 Patients y \u2227 Mutations y \u2227 Activating y \u2227 CTNNB1 y\" sledgehammer', 'solving time': 103.15814733505249, 'proof tactics': [], 'code': 'theory clinical_23_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutations :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  Inhibiting :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Leads :: \"event \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Through :: \"entity \u21d2 entity \u21d2 bool\"\\n  To :: \"event \u21d2 entity \u21d2 bool\"\\n  Reducing :: \"entity \u21d2 bool\"\\n  CellProliferation :: \"entity \u21d2 bool\"\\n  By :: \"event \u21d2 entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Treating :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutations x \u2227 Activating x \u2227 CTNNB1 x \u2227 Proliferation y \u2227 Cells y \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z \u2227 BetaCatenin z\"\\n\\n(* Explanation 2: A YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. YAPInhibitor x \u2227 Effective x \u2227 Inhibiting y \u2227 BetaCateninActivity y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. Inhibiting x \u2227 BetaCateninActivity x \u2227 Proliferation y \u2227 Cells y \u2227 Reduce e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Mutations z \u2227 Activating z \u2227 CTNNB1 z \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 y\"\\n\\n(* Explanation 4: Inhibiting \u03b2-catenin activity through a YAP inhibitor directly leads to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3. Inhibiting x \u2227 BetaCateninActivity x \u2227 YAPInhibitor y \u2227 Through x y \u2227 Leads e1 \u2227 Agent e1 x \u2227 Treatment z \u2227 Effective z \u2227 Patients z \u2227 Mutations z \u2227 Activating z \u2227 CTNNB1 z \u2227 To e1 z \u2227 Reducing w \u2227 CellProliferation w \u2227 By e1 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 Patients y \u2227 Mutations y \u2227 Activating y \u2227 CTNNB1 y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 Effective x \u2227 Treating y \u2227 Patients y \u2227 Mutations y \u2227 Activating y \u2227 CTNNB1 y\"\\nproof -\\n  (* From the premise, we have the known information about YAP inhibitor and patients with activating CTNNB1 mutations. *)\\n  from asm have \"YAPInhibitor x \u2227 Patients y \u2227 Mutations y \u2227 Activating y \u2227 CTNNB1 y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentence 4. *)\\n  (* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)\\n  then have \"Effective x \u2227 Treating y \u2227 Patients y \u2227 Mutations y \u2227 Activating y \u2227 CTNNB1 y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: \u03b2-catenin activity (from Explanatory Sentence 1 and 2)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(\u03b2-catenin activity))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(\u03b2-catenin activity), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), \u03b2-catenin activity)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, \u03b2-catenin activity)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(\u03b2-catenin activity), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(\u03b2-catenin activity), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "4 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, E), Implies(YAP inhibitor, treatment of patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, E is from explanatory sentence 4 and 5. *)\\n(* We already have YAPInhibitor x, so we can infer treatment of patients with activating CTNNB1 mutations. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 103.14865446090698, 'proof tactics': [], 'code': 'theory clinical_23_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  Proliferation :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  EffectiveInInhibiting :: \"entity \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 entity \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  CellProliferation :: \"event \u21d2 bool\"\\n  Inhibiting :: \"event \u21d2 bool\"\\n  Leads :: \"event \u21d2 bool\"\\n  EffectiveTreatment :: \"event \u21d2 bool\"\\n  Treatment :: \"event \u21d2 bool\"\\n  Reduces :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCatenin z \u2227 Proliferation e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z\"\\n\\n(* Explanation 2: A YAP inhibitor may be effective in inhibiting \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. YAPInhibitor x \u2227 BetaCateninActivity y \u27f6 EffectiveInInhibiting x y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e1 e2. BetaCateninActivity x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 Proliferation e1 \u2227 Cause e1 z \u27f6 (Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y)\"\\n\\n(* Explanation 4: Inhibiting \u03b2-catenin activity through a YAP inhibitor directly leads to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 CTNNB1Mutation z \u2227 CellProliferation e1 \u2227 Inhibiting e2 \u2227 Agent e2 y \u2227 Patient e2 z \u2227 Leads e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 EffectiveTreatment e3\"\\n\\n(* Explanation 5: A YAP inhibitor, by inhibiting \u03b2-catenin activity, effectively reduces cell proliferation, leading to the treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y z e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 CellProliferation e1 \u2227 Inhibiting e1 \u2227 Agent e1 y \u2227 Patient e1 z \u2227 Reduces e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Leads e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 Treatment e3\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about the YAP inhibitor and CTNNB1 mutation. *)\\n  from asm have \"YAPInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentence 4 and 5. *)\\n  (* We already have YAPInhibitor x, so we can infer treatment of patients with activating CTNNB1 mutations. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: \u03b2-catenin activity (from Explanatory Sentence 1 and 2)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: treatment of patients with activating CTNNB1 mutations (from Explanatory Sentence 4 and 5)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(\u03b2-catenin activity))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(\u03b2-catenin activity), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(treatment of patients with activating CTNNB1 mutations), \u03b2-catenin activity)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, \u03b2-catenin activity)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(\u03b2-catenin activity), treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(\u03b2-catenin activity), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, E is from explanatory sentence 4. *)\\n(* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 103.4877119064331, 'proof tactics': [], 'code': 'theory clinical_23_5\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"entity \u21d2 entity \u21d2 bool\"\\n  CellProliferation :: \"entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  EffectiveTreatment :: \"event \u21d2 entity \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Through e z\"\\n\\n(* Explanation 2: A YAP inhibitor can inhibit \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e1 e2. BetaCateninActivity x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause z y\"\\n\\n(* Explanation 4: A YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which leads to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 CellProliferation y \u2227 BetaCateninActivity z \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Lead e3 \u2227 Agent e3 x \u2227 EffectiveTreatment e3 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about the YAP inhibitor and activating CTNNB1 mutations. *)\\n  from asm have \"YAPInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentence 4. *)\\n  (* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: activity of \u03b2-catenin (from Explanatory Sentence 1)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentence 3 and 4)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(activating mutations of CTNNB1, B & C)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(activity of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(activity of \u03b2-catenin), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), activity of \u03b2-catenin)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, activity of \u03b2-catenin)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(proliferation of cells), Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(activity of \u03b2-catenin), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(activity of \u03b2-catenin), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "6 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 11.367790460586548, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  EffectiveTreatment :: event \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   x :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_23_6\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"entity \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  EffectiveTreatment :: \"event \u21d2 entity \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Through e z\"\\n\\n(* Explanation 2: A YAP inhibitor can inhibit \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. BetaCateninActivity x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause z y\"\\n\\n(* Explanation 4: A YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which leads to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Lead e3 \u2227 Agent e3 x \u2227 EffectiveTreatment e3 w\"\\n\\n(* Explanation 5: The reduction in cell proliferation caused by a YAP inhibitor\\'s inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Contribute e3 \u2227 Agent e3 x \u2227 EffectiveTreatment e3 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 CTNNB1Mutation y \u27f6 EffectiveTreatment x y\"\\nproof -\\n  (* From the premise, we have known information about the YAP inhibitor and activating CTNNB1 mutations. *)\\n  from asm have \"YAPInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentences 3, 4, and 5. *)\\n  (* We already have YAPInhibitor x, so we can infer EffectiveTreatment x y. *)\\n  then have \"EffectiveTreatment x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: activity of \u03b2-catenin (from Explanatory Sentence 1)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentences 3, 4, and 5)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(activating mutations of CTNNB1, B & C)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(activity of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(activity of \u03b2-catenin), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), activity of \u03b2-catenin)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, activity of \u03b2-catenin)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(proliferation of cells), Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(activity of \u03b2-catenin), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(activity of \u03b2-catenin), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "7 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, E is from explanatory sentences 3, 4, and 5. *)\\n(* We already have YAPInhibitor x, so we can infer EffectiveInTreating e y. *)\\nthen have \"EffectiveInTreating e y\" sledgehammer', 'solving time': 103.40967440605164, 'proof tactics': [], 'code': 'theory clinical_23_7\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"event \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Through e z\"\\n\\n(* Explanation 2: A YAP inhibitor can inhibit \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. BetaCateninActivity x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 Reduce e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 y\"\\n\\n(* Explanation 4: Reducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z e. Cell x \u2227 Patient e y \u2227 CTNNB1Mutation y \u2227 Reduce e \u2227 Agent e x \u2227 EffectiveInTreating e y\"\\n\\n(* Explanation 5: A YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which leads to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Cell z \u2227 Patient e w \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Lead e3 \u2227 Agent e3 x \u2227 EffectiveInTreating e3 w\"\\n\\n(* Explanation 6: The reduction in cell proliferation caused by a YAP inhibitor\\'s inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_6: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Cell z \u2227 Patient e w \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Contribute e3 \u2227 Agent e3 x \u2227 EffectiveInTreating e3 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating e y\"\\nproof -\\n  (* From the premise, we have the known information about the YAP inhibitor and CTNNB1 mutation. *)\\n  from asm have \"YAPInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentences 3, 4, and 5. *)\\n  (* We already have YAPInhibitor x, so we can infer EffectiveInTreating e y. *)\\n  then have \"EffectiveInTreating e y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: activity of \u03b2-catenin (from Explanatory Sentence 1)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentences 3, 4, and 5)\\n\\nLogical Relations:\\nImplies(A, Implies(C, B))\\nImplies(activating mutations of CTNNB1, Implies(activity of \u03b2-catenin, proliferation of cells))\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(activity of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(activity of \u03b2-catenin), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), activity of \u03b2-catenin)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(activity of \u03b2-catenin), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n'}",
            "8 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 11.999170064926147, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  EffectiveInTreating :: event \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   x :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_23_8\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"entity \u21d2 entity \u21d2 bool\"\\n  EffectiveInTreating :: \"event \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Directly :: \"event \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Through e z\"\\n\\n(* Explanation 2: A YAP inhibitor can inhibit \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e1 e2. BetaCateninActivity x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause z y\"\\n\\n(* Explanation 4: Reducing the proliferation of cells is effective in treating patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_4: \"\u2200x y z e. Cell x \u2227 CTNNB1Mutation y \u2227 Reduce e \u2227 Agent e x \u2227 EffectiveInTreating e y\"\\n\\n(* Explanation 5: A YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y z e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Cell z \u2227 CTNNB1Mutation z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Lead e3 \u2227 Agent e3 x \u2227 Directly e3 \u2227 EffectiveInTreating e3 z\"\\n\\n(* Explanation 6: The reduction in cell proliferation caused by a YAP inhibitor\\'s inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_6: \"\u2203x y z e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Cell z \u2227 CTNNB1Mutation z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Contribute e3 \u2227 Agent e3 x \u2227 Directly e3 \u2227 EffectiveInTreating e3 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about the YAP inhibitor and activating CTNNB1 mutations. *)\\n  from asm have \"YAPInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, E is from explanatory sentences 3, 4, and 5. *)\\n  (* We already have YAPInhibitor x, so we can infer EffectiveInTreating x y. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: activity of \u03b2-catenin (from Explanatory Sentence 1)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentences 3, 4, and 5)\\n\\nLogical Relations:\\nImplies(A, And(C, B))\\nImplies(activating mutations of CTNNB1, B & C)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(activity of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(activity of \u03b2-catenin), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), activity of \u03b2-catenin)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, activity of \u03b2-catenin)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(proliferation of cells), Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(activity of \u03b2-catenin), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(activity of \u03b2-catenin), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "9 iteration: {'syntactic validity': True, 'error code': '(* There is a derived implication Implies(D, E), which states that a YAP inhibitor implies effective treatment of patients with activating CTNNB1 mutations. *)\\n(* Since we have YAPInhibitor x, we can infer the effective treatment. *)\\nthen have \"\u2203e. EffectiveTreatment e y\" sledgehammer', 'solving time': 103.33441066741943, 'proof tactics': [], 'code': 'theory clinical_23_9\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Directly :: \"event \u21d2 bool\"\\n  EffectiveTreatment :: \"event \u21d2 entity \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Through e z\"\\n\\n(* Explanation 2: A YAP inhibitor can inhibit \u03b2-catenin activity. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Inhibit e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 3: Inhibiting \u03b2-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e1 e2. BetaCateninActivity x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause e2 z\"\\n\\n(* Explanation 4: A YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 BetaCateninActivity w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 w \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Lead e3 \u2227 Agent e3 y \u2227 Directly e3 \u2227 EffectiveTreatment e3 z\"\\n\\n(* Explanation 5: The reduction in cell proliferation caused by a YAP inhibitor\\'s inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 Cell y \u2227 CTNNB1Mutation z \u2227 BetaCateninActivity w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient e1 w \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Contribute e3 \u2227 Agent e3 y \u2227 Directly e3 \u2227 EffectiveTreatment e3 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 CTNNB1Mutation y \u27f6 (\u2203e. EffectiveTreatment e y)\"\\nproof -\\n  (* From the premise, we have known information about YAP inhibitor and activating CTNNB1 mutations. *)\\n  from asm have \"YAPInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a derived implication Implies(D, E), which states that a YAP inhibitor implies effective treatment of patients with activating CTNNB1 mutations. *)\\n  (* Since we have YAPInhibitor x, we can infer the effective treatment. *)\\n  then have \"\u2203e. EffectiveTreatment e y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: activity of \u03b2-catenin (from Explanatory Sentence 1)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, And(C, B))\\nImplies(activating mutations of CTNNB1, B & C)\\n--------\\nImplies(D, Not(C))\\nImplies(YAP inhibitor, Not(activity of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(activity of \u03b2-catenin), Not(proliferation of cells))\\n--------\\nImplies(Not(B), E)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(E), C)\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), activity of \u03b2-catenin)\\n--------\\nImplies(A, C)\\nImplies(activating mutations of CTNNB1, activity of \u03b2-catenin)\\n--------\\nImplies(A, Not(D))\\nImplies(activating mutations of CTNNB1, Not(YAP inhibitor))\\n--------\\nImplies(A, B)\\nImplies(activating mutations of CTNNB1, proliferation of cells)\\n--------\\nImplies(D, Not(A))\\nImplies(YAP inhibitor, Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(proliferation of cells), Not(activating mutations of CTNNB1))\\n--------\\nImplies(Not(C), E)\\nImplies(Not(activity of \u03b2-catenin), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(activity of \u03b2-catenin), Not(activating mutations of CTNNB1))\\n--------\\n'}",
            "10 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(D, F), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n(* D is from explanatory sentence 2, F is from explanatory sentence 3. *)\\n(* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 103.17577624320984, 'proof tactics': [], 'code': 'theory clinical_23_10\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  BetaCateninActivity :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  NecessaryFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 entity \u21d2 bool\"\\n  CellProliferation :: \"entity \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  LeadDirectly :: \"event \u21d2 bool\"\\n  EffectiveTreatment :: \"event \u21d2 entity \u21d2 bool\"\\n  ContributeDirectly :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. CTNNB1Mutation x \u2227 Cell y \u2227 BetaCateninActivity z \u2227 Promote e \u2227 Agent e x \u2227 Patient y \u2227 Through e z\"\\n\\n(* Explanation 2: A YAP inhibitor can inhibit \u03b2-catenin activity, which is necessary for the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 Cell z \u2227 CTNNB1Mutation z \u2227 Inhibit e2 \u2227 Agent e2 x \u2227 Patient y \u2227 NecessaryFor y z \u2227 Cause e1 z\"\\n\\n(* Explanation 3: A YAP inhibitor, by inhibiting \u03b2-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 CellProliferation z \u2227 Patient w \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient y \u2227 Reduce e2 \u2227 Agent e2 x \u2227 Patient z \u2227 LeadDirectly e3 \u2227 Agent e3 z \u2227 EffectiveTreatment e3 w\"\\n\\n(* Explanation 4: The reduction in cell proliferation caused by a YAP inhibitor\\'s inhibition of \u03b2-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3. YAPInhibitor x \u2227 BetaCateninActivity y \u2227 CellProliferation z \u2227 Patient w \u2227 CTNNB1Mutation w \u2227 Inhibit e1 \u2227 Agent e1 x \u2227 Patient y \u2227 Cause e1 z \u2227 ContributeDirectly e2 \u2227 Agent e2 z \u2227 EffectiveTreatment e3 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"YAPInhibitor x \u2227 Patient y \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. YAPInhibitor x \u2227 Patient y \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have the known information about the YAP inhibitor, patient, and CTNNB1 mutation. *)\\n  from asm have \"YAPInhibitor x \u2227 Patient y \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a logical relation Implies(D, F), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)\\n  (* D is from explanatory sentence 2, F is from explanatory sentence 3. *)\\n  (* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nB: proliferation of cells (from Explanatory Sentence 1)\\nC: activity of \u03b2-catenin (from Explanatory Sentence 1)\\nD: YAP inhibitor (from Explanatory Sentence 2)\\nE: inhibit \u03b2-catenin activity (from Explanatory Sentence 2)\\nF: effective treatment of patients with activating CTNNB1 mutations (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, Implies(C, B))\\nImplies(activating mutations of CTNNB1, Implies(activity of \u03b2-catenin, proliferation of cells))\\n--------\\nImplies(D, E)\\nImplies(YAP inhibitor, inhibit \u03b2-catenin activity)\\n--------\\nImplies(E, Not(B))\\nImplies(inhibit \u03b2-catenin activity, Not(proliferation of cells))\\n--------\\nImplies(Not(B), F)\\nImplies(Not(proliferation of cells), effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(D))\\nImplies(proliferation of cells, Not(YAP inhibitor))\\n--------\\nImplies(Not(F), Not(D))\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), Not(YAP inhibitor))\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(effective treatment of patients with activating CTNNB1 mutations), Not(inhibit \u03b2-catenin activity))\\n--------\\nImplies(D, F)\\nImplies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\nImplies(D, Not(B))\\nImplies(YAP inhibitor, Not(proliferation of cells))\\n--------\\nImplies(E, F)\\nImplies(inhibit \u03b2-catenin activity, effective treatment of patients with activating CTNNB1 mutations)\\n--------\\n'}"
        ]
    }
}